Increased expression of alpha-1-antitrypsin, glutathione S-transferase pi and vascular endothelial growth factor in human pancreatic adenocarcinoma.

[1]  N. Lemoine,et al.  Inherited predisposition to pancreatic cancer , 2001, Gut.

[2]  R. Chambers,et al.  Alpha‐1‐antitrypsin stimulates fibroblast proliferation and procollagen production and activates classical MAP kinase signalling pathways , 2001, Journal of cellular physiology.

[3]  Taylor Murray,et al.  Cancer Statistics, 2001 , 2001, CA: a cancer journal for clinicians.

[4]  C. Yeo,et al.  The molecular genetics of pancreatic ductal carcinoma: a review. , 2000, Surgical oncology.

[5]  W. Peters,et al.  Expression of Glutathione S‐Transfer α, P1–1 and T1–1 in the Human Gastrointestinal Tract , 2000, Japanese journal of cancer research : Gann.

[6]  H. Friess,et al.  Pancreatic cancer--new aspects of molecular biology research. , 2000, Swiss surgery = Schweizer Chirurgie = Chirurgie suisse = Chirurgia svizzera.

[7]  Y. Kohgo,et al.  α-Fetoprotein-producing adenocarcinoma of the pancreas presenting focal hepatoid differentiation , 1999, International journal of pancreatology : official journal of the International Association of Pancreatology.

[8]  T. Veikkola,et al.  VEGFs, receptors and angiogenesis. , 1999, Seminars in cancer biology.

[9]  M. Bittner,et al.  Expression profiling in cancer using cDNA microarrays , 1999, Electrophoresis.

[10]  R. Hruban,et al.  Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas. , 1998, Cancer research.

[11]  R. Hruban,et al.  Tumor-suppressor genes in pancreatic cancer. , 1998, Journal of hepato-biliary-pancreatic surgery.

[12]  J. Cameron,et al.  Prognostic factors in ductal pancreatic cancer , 1998, Langenbeck's Archives of Surgery.

[13]  K. Kinzler,et al.  Identifying markers for pancreatic cancer by gene expression analysis. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[14]  M. Mizumoto,et al.  Identification of a neutrophil gelatinase-associated lipocalin mRNA in human pancreatic cancers using a modified signal sequence trap method. , 1998, Cancer letters.

[15]  Y. Okada,et al.  Membrane-Type Matrix Metalloproteinases (MT-MMPs) in Cell Invasion , 1997, Thrombosis and Haemostasis.

[16]  S. Goodman,et al.  Tumor-suppressive pathways in pancreatic carcinoma. , 1997, Cancer research.

[17]  N. Papadopoulos,et al.  Molecular basis of HNPCC: Mutations of MMR genes , 1997, Human mutation.

[18]  J. Hayes,et al.  The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. , 1995, Critical reviews in biochemistry and molecular biology.

[19]  S. Batra,et al.  Molecular cloning and sequence analysis of the human ribosomal protein S16. , 1991, The Journal of biological chemistry.

[20]  Y. Niitsu,et al.  Serum glutathione‐s‐transferase‐π as a tumor marker for gastrointestinal malignancies , 1989 .

[21]  R. Senior,et al.  The inhibitory complex of human alpha 1-proteinase inhibitor and human leukocyte elastase is a neutrophil chemoattractant , 1988, The Journal of experimental medicine.

[22]  G. Salvesen,et al.  Human plasma proteinase inhibitors. , 1983, Annual review of biochemistry.

[23]  H. Freeman,et al.  Alpha1-antitrypsin deficiency and pancreatic fibrosis. , 1976, Annals of internal medicine.

[24]  C. Alper,et al.  Changes in serum proteinase inhibitor levels following bone surgery. , 1974, Clinica chimica acta; international journal of clinical chemistry.

[25]  W. Troll,et al.  Tumorigenesis in Mouse Skin: Inhibition by Synthetic Inhibitors of Proteases , 1970, Science.